Vilon Dosing Protocol: 20 mg Vial — Dipeptide Immune & Longevity Bioregulator Guide
Vilon (Lys-Glu dipeptide) bioregulator: community-reported dosing, reconstitution math for the 20 mg vial, and what the research does and doesn't support.
Quickstart highlights
Vilon is the synthetic dipeptide Lys-Glu (KE), developed by Vladimir Khavinson's group in St.
- No human dose has been established. Every amount on this page is community-reported, not from a trial.
- For the commonly quoted 200 µg: 20 mg vial + 10 mL bac water = 2 mg/mL, so 200 µg = 10 units.
- At 200 µg per dose, one 20 mg vial holds 100 doses; a 10-day course uses 2 mg.
- Mouse studies used far smaller amounts, such as 0.1 µg per mouse for five days a month.
- The research behind Vilon is mostly cell and rodent work. See the Vilon peptide page for the evidence.
Dosing table
For educational reference only. Your prescribing provider may adjust doses based on your clinical profile and response.
| Week | Dose (µg) | Units | Frequency | Notes |
|---|---|---|---|---|
| 1-2 (10-day course) | 200 | 10 | Once daily | Community-reported, not from a trial; 200 µg = 10 units at 2 mg/mL; one 20 mg vial holds 100 doses at this amount |
| Maintenance | 200 | 10 | Every other day | Community-reported, not from a trial; no study has tested a maintenance schedule or long-term use in people |
Your free Vilon tracker
- Dose reminders
- Injection logging
- Cycle progress
Reconstitution steps
- Add 10 mL bacteriostatic water to the 20 mg vial (for example in four 2.5 mL portions), running it slowly down the vial wall.
- Swirl gently until dissolved; do not shake.
- Final concentration: 2 mg/mL. On a U-100 insulin syringe, 200 µg = 10 units.
- Label with the date; refrigerate at 2–8 °C and use within 28 days.
Supplies needed
10_day-week plan
- 1 vial
- 10 syringes
- 10 mL bac water
- 10 alcohol swabs
Protocol overview & cycle notes
Reference schedule and reconstitution math for a 20 mg Vilon vial. Vilon has cell and rodent research but only one small human study, so every dose on this page is community-reported, not clinically established.
Off-cycle: Not established. Community sources describe breaks of months between courses; no study has tested cycle length in people.
Storage & handling
Injection & tracking tips
- Community protocols describe subcutaneous injection into abdominal or thigh fat; no study has compared routes or timing of day in people.
- Rotate injection sites and use a new sterile syringe every time.
- No study has tested this peptide combined with any other peptide, so combination protocols are untested.
- Vilon is promoted as an immune modulator and has no human safety data. If you have an autoimmune disease, an organ transplant or take immune-suppressing drugs, talk to your physician first.
Tracking
Logging helps you and your provider spot patterns and adjust dose or timing.
- Record the start date, amount, product lot and certificate of analysis for each course.
- If your physician orders immune or inflammation labs, get them at baseline and after the course; no study has shown Vilon changes them in people.
- Note any side effects, including injection-site reactions, and share them with your physician.
How this works & references
Sources
- Anisimov VN, et al. Effect of synthetic thymic and pineal peptides on biomarkers of ageing, survival and spontaneous tumour incidence in female CBA mice. Mech Ageing Dev. 2001. PMID: 11163623
- Khavinson VK, et al. Effect of vilon on biological age and lifespan in mice. Bull Exp Biol Med. 2000. PMID: 11140587
- Khavinson VK, et al. Effect of peptide Lys-Glu on interleukin-2 gene expression in lymphocytes. Bull Exp Biol Med. 2000. PMID: 11177276
- Lezhava T, et al. Bioregulator Vilon-induced reactivation of chromatin in cultured lymphocytes from old people. Biogerontology. 2004. PMID: 15105581
- Kuznik BI, et al. Effect of thymomimetic vilon on blood coagulation system and fibrinolisis in diabetes mellitus type 1 patients of different age. Adv Gerontol. 2006. PMID: 17152731
- Anisimov SV, et al. Studies of the effects of Vilon and Epithalon on gene expression in mouse heart using DNA-microarray technology. Bull Exp Biol Med. 2002. PMID: 12360356
- Khavinson V, et al. Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers. Int J Mol Sci. 2022. PMID: 35887081
Frequently asked questions
What is the Vilon peptide dosage?
What is Vilon peptide used for?
What are the side effects of Vilon?
Can Vilon be taken orally?
Can Vilon be combined with Epitalon?
Related protocols
KLOW Blend Dosing Protocol — BPC-157, TB-500, KPV & GHK-Cu Guide
KLOW peptide blend (BPC-157 + TB-500 + KPV + GHK-Cu) dosing guide for tissue repair, anti-inflammatory support, and extracellular matrix remodeling — the GLOW blend plus KPV.
View protocolGLOW Blend Dosing Protocol — BPC-157, TB-500 & GHK-Cu Skin & Repair Guide
GLOW peptide blend (BPC-157 + TB-500 + GHK-Cu) dosing guide for tissue repair, angiogenesis, and collagen and connective-tissue remodeling.
View protocolVesugen Dosing Protocol: 20 mg Vial — Vascular Bioregulator & Cardiovascular Guide
Vesugen (Lys-Glu-Asp tripeptide) Russian vascular bioregulator dosing guide — endothelial cell gene normalization for arterial health, blood pressure regulation, and cardiovascular aging.
View protocolTestagen Dosing Protocol: 20 mg Vial, Reconstitution & Units
Testagen (Lys-Glu-Asp-Gly tetrapeptide) bioregulator: community-reported dosing, reconstitution math for the 20 mg vial, and what the research does and doesn't support.
View protocolThis content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any peptide therapy. Dosing and protocols may vary by formulation and prescriber.
